Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Zaynab Ahmad Mouhammad"'
Autor:
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco, Miriam Kolko
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
Glaucoma is a common ocular neurodegenerative disease characterized by the progressive loss of retinal ganglion cells and their axons. It is the most common cause of irreversible blindness. With an increasing number of glaucoma patients and disease p
Externí odkaz:
https://doaj.org/article/3d5a9abd5d1140799c5500d35520ec6b
Autor:
Steffen Heegaard, Anne Hedengran, Miriam Kolko, Tor P Utheim, Darlene A Dartt, Goran Petrovski, Olivia Müllertz, Zaynab Ahmad Mouhammad, Josefine Freiberg, Richárd Nagymihály, Jette Jacobsen, Susan Weng Larsen, Jeffrey Bair
Publikováno v:
BMJ Open Ophthalmology, Vol 6, Iss 1 (2021)
Objective To investigate the short-term impact on human conjunctival goblet cell (GC) survival and mucin release of acute exposure to benzalkonium chloride (BAK) preserved and preservative-free (PF) 0.005% (w/v) latanoprost (LT) eye drops, and to com
Externí odkaz:
https://doaj.org/article/2731e9f64c1545518e8457f28a8aeb5f
Autor:
Rupali Vohra, Berta Sanz-Morello, Anna Luna Mølgaard Tams, Zaynab Ahmad Mouhammad, Kristine Karla Freude, Jens Hannibal, Blanca Irene Aldana, Linda Hildegaard Bergersen, Miriam Kolko
Publikováno v:
Cells, Vol 11, Iss 13, p 2098 (2022)
Background: Progressive retinal ganglion cell (RGC) dysfunction and death are common characteristics of retinal neurodegenerative diseases. Recently, hydroxycarboxylic acid receptor 1 (HCA1R, GPR81) was identified as a key modulator of mitochondrial
Externí odkaz:
https://doaj.org/article/8212d40408d9464f8ddaca39ba76fadf
Autor:
Xenia Begun, Barbara Cvenkel, Miriam Kolko, Jeffrey Bair, Rupali Vohra, Goran Petrovski, Zaynab Ahmad Mouhammad, Darlene A. Dartt, Olivia Müllertz, Steffen Heegaard, Anne Hedengran
Publikováno v:
Biomedicine Hub, Vol 6, Iss 2, Pp 69-76 (2021)
Hedengran, A, Begun, X, Müllertz, O, Mouhammad, Z, Vohra, R, Bair, J, Dartt, D A, Cvenkel, B, Heegaard, S, Petrovski, G & Kolko, M 2021, ' Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro ', Biomedicine Hub, vol. 6, no. 2, pp. 69-75 . https://doi.org/10.1159/000517845
Biomed Hub
Hedengran, A, Begun, X, Müllertz, O, Mouhammad, Z, Vohra, R, Bair, J, Dartt, D A, Cvenkel, B, Heegaard, S, Petrovski, G & Kolko, M 2021, ' Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro ', Biomedicine Hub, vol. 6, no. 2, pp. 69-75 . https://doi.org/10.1159/000517845
Biomed Hub
Introduction: Most intraocular pressure (IOP)-lowering eye drops are preserved with benzalkonium chloride (BAK). This can increase side effects and decrease adherence. Particularly, damage to the mucin-producing conjunctival goblet cells may be an is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a1f2b8727cae0ff197b38fb7f7361f5
https://www.karger.com/Article/FullText/517845
https://www.karger.com/Article/FullText/517845
Autor:
Blanca I. Aldana, Emil W. Westi, Rupali Vohra, Jens Hannibal, Miriam Kolko, Zaynab Ahmad Mouhammad, Berta Sanz-Morello, Kristine K. Freude, Anna Luna Mølgaard Tams, Jens V. Andersen
Publikováno v:
Cellular and Molecular Neurobiology. 42:291-303
Visual changes are some of the earliest symptoms that patients with Alzheimer’s disease (AD) experience. Pathophysiological processes such as amyloid-β plaque formation, vascular changes, neuroinflammation, and loss of retinal ganglion cells (RGCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3123c85c473787ffd5667c768f72a3
https://doi.org/10.1007/s10571-021-01126-y
https://doi.org/10.1007/s10571-021-01126-y
Autor:
Anna Luna Mølgaard, Tams, Berta, Sanz-Morello, Emil Winther, Westi, Zaynab Ahmad, Mouhammad, Jens Velde, Andersen, Kristine Karla, Freude, Rupali, Vohra, Jens, Hannibal, Blanca Irene, Aldana, Miriam, Kolko
Publikováno v:
Acta Ophthalmologica. 100
Visual changes are some of the earliest symptoms that patients with Alzheimer's disease (AD) experience. Pathophysiological processes such as amyloid-β plaque formation, vascular changes, neuroinflammation, and loss of retinal ganglion cells (RGCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17f589a7ecc1bd0b8aba9ad00bc4a3c
https://doi.org/10.1111/j.1755-3768.2022.178
https://doi.org/10.1111/j.1755-3768.2022.178
Autor:
Rupali Vohra, Anna Luna Mølgaard Tams, Berta Sanz Morello, Zaynab Ahmad Mouhammad, Jens Hannibal, Linda Hildegaard Bergersen, Miriam Kolko
Publikováno v:
Acta Ophthalmologica. 100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4126cc8b31e4bd27e550070c393c19e4
https://doi.org/10.1111/j.1755-3768.2022.002
https://doi.org/10.1111/j.1755-3768.2022.002
Autor:
Olivia Müllertz, Anne Nagstrup, Zaynab Ahmad Mouhammad, Josefine Clement Freiberg, Richard Nagymihaly, Jette Jacobsen, Susan Larsen, Jeffrey Bair, Tor Paaske Utheim, Darlene Dartt, Steffen Heegaard, Goran Petrovski, Miriam Kolko
Publikováno v:
Acta Ophthalmologica. 100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7895e0d6e22cd5806b26ac1f814c8ba
https://doi.org/10.1111/j.1755-3768.2022.071
https://doi.org/10.1111/j.1755-3768.2022.071
Autor:
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco, Miriam Kolko
Publikováno v:
Mouhammad, Z A, Vohra, R, Horwitz, A, Thein, A-S, Rovelt, J, Cvenkel, B, Williams, P A, Azuara-Blanco, A & Kolko, M 2022, ' Glucagon-Like Peptide 1 Receptor Agonists-Potential Game Changers in the Treatment of Glaucoma? ', Frontiers in Neuroscience, vol. 16, 824054 . https://doi.org/10.3389/fnins.2022.824054
Mouhammad, Z A, Vohra, R, Horwitz, A, Thein, A S, Rovelt, J, Cvenkel, B, Williams, P A, Azuara-Blanco, A & Kolko, M 2022, ' Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma? ', Frontiers in Neuroscience, vol. 16, 824054 . https://doi.org/10.3389/fnins.2022.824054
Mouhammad, Z A, Vohra, R, Horwitz, A, Thein, A S, Rovelt, J, Cvenkel, B, Williams, P A, Azuara-Blanco, A & Kolko, M 2022, ' Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma? ', Frontiers in Neuroscience, vol. 16, 824054 . https://doi.org/10.3389/fnins.2022.824054
Glaucoma is a common ocular neurodegenerative disease characterized by the progressive loss of retinal ganglion cells and their axons. It is the most common cause of irreversible blindness. With an increasing number of glaucoma patients and disease p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a904525bba5e3f27d84d73ca249ffc
https://pubmed.ncbi.nlm.nih.gov/35264926
https://pubmed.ncbi.nlm.nih.gov/35264926
Autor:
Sarkis Saruhanian, Zaynab Ahmad Mouhammad, Bokkyoo Jun, Thisayini Baskaran, Nicolas G. Bazan, Daniel Tiedemann, Anne Katrine Toft-Kehler, Rupali Vohra, Miriam Kolko, Mia Langbøl
Publikováno v:
Journal of Clinical Medicine; Volume 9; Issue 9; Pages: 2979
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2979, p 2979 (2020)
Langbol, M, Saruhanian, S, Baskaran, T, Tiedemann, D, Mouhammad, Z A, Toft-Kehler, A K, Jun, B, Vohra, R, Bazan, N G & Kolko, M 2020, ' Increased Antioxidant Capacity and Pro-Homeostatic Lipid Mediators in Ocular Hypertension-A Human Experimental Model ', Journal of Clinical Medicine, vol. 9, no. 9, 2979 . https://doi.org/10.3390/jcm9092979
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2979, p 2979 (2020)
Langbol, M, Saruhanian, S, Baskaran, T, Tiedemann, D, Mouhammad, Z A, Toft-Kehler, A K, Jun, B, Vohra, R, Bazan, N G & Kolko, M 2020, ' Increased Antioxidant Capacity and Pro-Homeostatic Lipid Mediators in Ocular Hypertension-A Human Experimental Model ', Journal of Clinical Medicine, vol. 9, no. 9, 2979 . https://doi.org/10.3390/jcm9092979
The main risk factor for primary open-angle glaucoma (POAG) is increased intraocular pressure (IOP). It is of interest that about half of the patients have an IOP within the normal range (normal-tension glaucoma, NTG). Additionally, there is a group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03405837326f7d961e6c8e6cb0163485